118

News

Danish pharma company on cusp of international success

TheCopenhagenPost
March 1st, 2016


This article is more than 8 years old.

Diabetes drug could be headed to the US

Danish pharma company headed for the big time (photo; Sanofil)

Danish pharmaceutical company Danske Zealand Pharma has taken a major step in capitalising on its diabetes product Lyxumia.

The Glostrup-based firm and its partner Sanofi has received approval for a US application for the composite product Lixilan.

Lixilan is a mixture of Danske Zealand Pharma’s Lyxumia and the world’s best-selling insulin, Lantus Sanofios.

Now that the application has been officially processed, the company will find out in August if its product has been approved.

“The US approval of the application is an important milestone in the regulatory process for this new type of diabetes drug,” said Danske Zealand Pharma head Britt Meelby Jensen.

Profitable combination
Lyxumia is a GLP-1 analog that acts by stimulating the pancreatic production of insulin. It is the same type of product as Novo Nordisk’s Victoza, which earned 18 billion kroner in 2015.

Lyxumia as a single agent earned Dansk Zealand Pharma 21 million kroner in royalties in the first nine months of 2015.

READ MORE: Danish diabetes treatment among the best in Europe

The combination product Lixilan could help to considerably increase sales of Lyxumia.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”